Responses to purified RhD protein by T cells from patients with CLL with secondary AIHA when CD5+ CLL cells are used as APCs
No. CLL + AIHA patients tested . | 2 . | 2 . | 3 . | 3 . | 4 . | 4 . | 5 . | 6 . | 9 . | 10 . | 11 . | 11 . | 12 . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Change in response, % | 245 | 818 | 201 | 160 | 151 | 85 | 333 | 356 | 173 | 140 | 167 | 239 | 119 |
No. CLL + AIHA patients tested . | 2 . | 2 . | 3 . | 3 . | 4 . | 4 . | 5 . | 6 . | 9 . | 10 . | 11 . | 11 . | 12 . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Change in response, % | 245 | 818 | 201 | 160 | 151 | 85 | 333 | 356 | 173 | 140 | 167 | 239 | 119 |
Responses are shown relative to proliferation stimulated when unfractionated PBMCs act as APCs.